Browse by Journal Title
![]() | Up a level |
Number of items: 4.
F
Faisal Hamdi, Amir Imran and Poh, Wen Tsin and Lim, Jonathan Chee Woei and Daut, Ummi Nadira and How, Soon Hin and Pang, Yong Kek and Stanslas, Johnson
(2025)
Intermittent afatinib treatment suppresses the growth of resistant T790M-H1975 cells in non-small cell lung cancer (NSCLC) co-culture.
Oncologie, 27 (6).
pp. 929-940.
ISSN 1292-3818; eISSN: 1765-2839
H
Hamdi, Amir Imran Faisal and Stanslas, Johnson
(2022)
Delaying emergence of resistance to KRAS inhibitors with adaptive therapy: “treatment-to-contain” instead of “treatment-to-cure”.
Oncologie, 24 (2).
185 - 194.
ISSN 1292-3818; ESSN: 1765-2839
T
Teh, Yuan Han and Jing, Rui and Ramasamy, Rajesh and Ho, Kok Lian and Sagineedu, Sreenivasa Rao and Stanslas, Johnson
(2025)
KRAS-driven pancreatic ductal adenocarcinoma cell lines harbour putative cancer stem cells.
Oncologie, 27 (5).
pp. 725-737.
ISSN 1292-3818; eISSN: 1765-2839
Y
Yuan, Han Teh and Rui, Jing and Ramasamy, Rajesh and Kok, Lian Ho and Sagineedu, Sreenivasa Rao and Stanslas, Johnson
(2023)
More than just a KRAS inhibitor: DCAI abrogates the self-renewal of pancreatic cancer stem cells in vitro.
Oncologie.
pp. 1-10.
ISSN 1292-3818; ESSN: 1765-2839
